b'SIU EVENTSPROGRAMME AGENDAFriday, November 11, 2022TIME EST SESSION TITLE INVITED SPEAKERS0800 Welcome and Introduction Peter Black and Simon Tanguay, CanadaBladder Cancer (Moderator: Alexandra Masson-Lecomte)08050820 Optimal surgical management of T1 bladder cancer Alexandra Masson-Lecomte, France08200835 Molecular risk stratification and precision therapy Eugene Pietzak, United Statesfor T1 bladder cancer08350850 Can ctDNA and utDNA be used to monitor NMIBC? Karin Birkenkamp-Demtrder, Denmark08500905 MRI for optimal assessment of T1 bladder cancer Andrea Kokorovic, Canada09050930 Debate: Adjuvant chemotherapy vs. adjuvant IO after Pro chemo: Evanguelos Xylinas, Franceradical cystectomy Pro IO: Srikala Sridhar, CanadaCase-Based Panel Discussion: Anything but radical Moderator: Alexandra Masson-Lecomte09301015 cystectomy! Bladder preservation in 2022 Panel: Eugene Pietzak, Andrea Kokorovic,Evanguelos Xylinas, Srikala Sridhar10151035 Advances in intraluminal therapy of upper tract Seth Lerner, United Statesurothelial carcinoma10351050 Coffee BreakProstate Cancer (Moderator: Derya Tilki) 10501110 Germline testing: who and how? Elena Castro, Spain11101130 Update on AI-derived predictive biomarkers Daniel Spratt, United States11301150 Management of pN1 disease Derya Tilki, Germany11501210 PSMA theranostics to target prostate cancer Andrew Laccetti, United States12101230 Challenges and progress in personalized therapy: Martin Gleave, CanadaLocalized prostate cancer12301250 Challenges and progress in personalized therapy: Himisha Beltran, United StatesMetastatic prostate cancer12501340 Lunch Break13401400 General GU talk: Financial toxicity Sarah Psutka, United StatesKidney Cancer (Moderator: Simon Tanguay)14001425 Debate: Adjuvant therapy should be offered to all high-risk Pro: Tian Zhang, United Statespatients post nephrectomy Con: Lori Wood, Canada14251445 Best options for the treatment of metastatic non-clear cell RCC Tian Zhang14451505 Pre-operation identification and optimal treatment of Philippe Spiess, United Statessarcomatoid RCC15051520 Coffee Break15201540 Limits of partial nephrectomy in localized RCC Simon Tanguay15401605 Debate:Is there a best regimen for first-line therapy in mRCC? Pro IO-IO: Christian Kollmannsberger, CanadaPro IO-TKI: Lori WoodFive Practice-Changing Advances on the Horizon (Moderators: Peter Black & Simon Tanguay)16051625 Bladder Cancer Sarah Psutka16251645 Kidney Cancer Philippe Spiess16451705 Prostate Cancer Rafael Sanchez-Salas, Canada1705 Concluding Remarks/Meeting adjourned Peter Black and Simon Tanguaywww.siu-urology.org 11'